Fig. 4From: Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolutionDistribution of serum ST2 and fecal calprotectin in patients rescued with biological therapy. Serum sST2 (a) and fecal calprotectin (b) levels are shown for patients non-responsive to conventional therapy or with reactivation but rescued with biological therapy. Each symbol in the scatter plot represents the measurement in individual patients; horizontal lines indicate medians and whiskers (the interquartile ranges). Differences were assessed using Kruskal-Wallis test with Dunn’s multiple comparison post-test (*p < 0.05 and **p < 0.01)Back to article page